These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9001825)

  • 41. Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro.
    Moreira AL; Corral LG; Ye W; Johnson B; Stirling D; Muller GW; Freedman VH; Kaplan G
    AIDS Res Hum Retroviruses; 1997 Jul; 13(10):857-63. PubMed ID: 9197379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells.
    Pollicita M; Ruff MR; Pert CB; Polianova MT; Schols D; Ranazzi A; Perno CF; Aquaro S
    Antivir Chem Chemother; 2007; 18(5):285-95. PubMed ID: 18046961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
    Poli G; Orenstein JM; Kinter A; Folks TM; Fauci AS
    Science; 1989 May; 244(4904):575-7. PubMed ID: 2470148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new class of anti-HIV-1 oligonucleotide targeted to the polypurine tract of viral RNA.
    Hiratou T; Miyano-Kurosaki N; Gushima H; Takaku H
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):715-8. PubMed ID: 11563099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Three-drug combination of MKC-442, lamivudine and zidovudine in vitro: potential approach towards effective chemotherapy against HIV-1.
    Piras G; Nakade K; Yuasa S; Baba M
    AIDS; 1997 Mar; 11(4):469-75. PubMed ID: 9084794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells.
    Mlynar E; Bevec D; Billich A; Rosenwirth B; Steinkasserer A
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():825-35. PubMed ID: 9129655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence of ongoing replication in a human immunodeficiency virus type 1 persistently infected cell line.
    Olivares I; Sánchez-Jiménez C; Vieira CR; Toledano V; Gutiérrez-Rivas M; López-Galíndez C
    J Gen Virol; 2013 May; 94(Pt 5):944-954. PubMed ID: 23288426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The multiple inhibitory mechanisms of GEM 91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1.
    Yamaguchi K; Papp B; Zhang D; Ali AN; Agrawal S; Byrn RA
    AIDS Res Hum Retroviruses; 1997 May; 13(7):545-54. PubMed ID: 9135872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes.
    Konopka K; Pretzer E; Felgner PL; Düzgüneş N
    Biochim Biophys Acta; 1996 Jul; 1312(3):186-96. PubMed ID: 8703987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
    J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Failure of azidothymidine to inhibit human immunodeficiency virus (HIV) replication in a promonocytic cell line (U937).
    Uherová P; Schmidtmayerová H; Mayer V
    Acta Virol; 1991 Aug; 35(4):357-64. PubMed ID: 1724875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-acetyl-cysteine and L-2-oxothiazolidine-4-carboxylic acid enhance contact-dependent growth of HIV in resting peripheral blood mononuclear cells (PBMC) in vitro and increase recovery of HIV from human-PBMC SCID mice.
    Chen P; Bauer G; Mitchell J; Factor R; Markham R; Schwartz DH
    AIDS; 1997 Jan; 11(1):33-41. PubMed ID: 9110073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of human immunodeficiency virus (HIV-1) infection by diphenylhydantoin (dilantin) implicates role of cellular calcium in virus life cycle.
    Cloyd MW; Lynn WS; Ramsey K; Baron S
    Virology; 1989 Dec; 173(2):581-90. PubMed ID: 2574518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus.
    Crowe SM; McGrath MS; Elbeik T; Kirihara J; Mills J
    J Med Virol; 1989 Nov; 29(3):176-80. PubMed ID: 2533247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells.
    Iordanskiy S; Van Duyne R; Sampey GC; Woodson CM; Fry K; Saifuddin M; Guo J; Wu Y; Romerio F; Kashanchi F
    Virology; 2015 Nov; 485():1-15. PubMed ID: 26184775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1.
    Su J; Andersson E; Horal P; Naghavi MH; Palm A; Wu YP; Eriksson K; Jansson M; Wigzell H; Svennerholm B; Vahlne A
    J Hum Virol; 2001; 4(1):1-7. PubMed ID: 11213928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stavudine selectively induces apoptosis in HIV type 1-infected cells.
    Hashimoto KI; Tsunoda R; Okamoto M; Shigeta S; Baba M
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):193-9. PubMed ID: 9007205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of target cell availability on HIV-1 production in vitro.
    Schwartz EJ; Neumann AU; Teixeira AV; Bruggeman LA; Rappaport J; Perelson AS; Klotman PE
    AIDS; 2002 Feb; 16(3):341-5. PubMed ID: 11834944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiviral profile of HIV inhibitors in macrophages: implications for therapy.
    Perno CF; Balestra E; Francesconi M; Abdelahad D; Caliò R; Balzarini J; Aquaro S
    Curr Top Med Chem; 2004; 4(9):1009-15. PubMed ID: 15134554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase.
    Müller-Calleja N; Manukyan D; Canisius A; Strand D; Lackner KJ
    Ann Rheum Dis; 2017 May; 76(5):891-897. PubMed ID: 27903507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.